{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#12 - Pascal Touchon, President and CEO at Atara Biotherapeutics","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a21bd7ce\"></iframe>","width":"100%","height":180,"duration":1029,"description":"Join us on the latest episode! Our Guest: Pascal Touchon, President and CEO at Atara BiotherapeuticsWhat you'll get out of this episode:- Backstory on Pascal- Leading CAR-T at Novartis and Atara, focusing on lymphoma.- Creation of EBV T Cell Platform for cancer and autoimmune diseases.- The milestones for Ebalo, including European approval.- Impacting cell therapy with validation, quality manufacturing.- Planned future directions, including FDA alignment and partnerships.To learn more about Atara Biotherapeutics: https://www.atarabio.com/Our sponsors for this episode are:Sage Growth Partners https://sage-growth.com/FlipMD by GoodRX https://www.goodrx.com/Quantum Health https://quantum-health.com/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}